Shortcut Navigation:
Print
Terms Used On This Page

Breast Cancer News

In this section, access cutting-edge news about breast cancer in young women including treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.

Women get less information on post-cancer fertility

NEW YORK (Reuters Health) - Cancer treatment can sometimes lead to infertility, but young women are less likely than young men to be informed of that risk, a new study suggests.

Infants Exposed to Chemotherapy During Pregnancy Develop Normally

Children born to mothers who had chemotherapy during pregnancy show long-term normal development.

Distress from Post-Treatment Infertility Remains Over Time

Younger women who want to become pregnant after treatment but are unable to conceive experience long-term emotional distress related to that infertility.

Pregnancy Safe for Women With Breast Cancer History

In this analysis of studies over 40 years, an international research team found that pregnancy is safe for women with a history of breast cancer and does not hurt overall survival. The study, published in the European Journal of Cancer, also looked at related issues, including why some research has shown a possibly protective effect of pregnancy.

Younger Women Experience Distinct Treatment-Related Effects

Young women diagnosed with breast cancer are more likely than healthy or older women with breast cancer to have difficulties with quality of life, fertility and menopausal concerns, and behavioral health, according to a systematic review.

Many young cancer patients don't discuss fertility

NEW YORK (Reuters Health) - Young women with cancer often aren't counseled about the risk of losing their fertility due to treatment or their options for saving their eggs, a new study from California suggests.

Tamoxifen Reduces ER-positive Recurrence Rate

In a five-year review of 20 clinical trials, tamoxifen was shown to safely reduce both 15-year risk for recurrence and death in early-stage estrogen receptor-positive breast cancer.

Zometa fails to help breast cancer survival: study

NEW YORK (Reuters) - The Novartis osteoporosis drug Zometa failed to improve disease free survival of early breast cancer patients in a large clinical trial, but some benefit was observed in older patients who took the medicine, researchers said.

Cancer patients pick antidepressant for hot flashes

NEW YORK (Reuters Health) - Breast cancer survivors who struggle with hot flashes may find respite in an antidepressant, according to a new study that suggests the medication should be the go-to drug when the overheating is severe.

Women prefer silicone to saline after mastectomy

NEW YORK (Reuters Health) - Women who have breast reconstruction after cancer surgery tend to be happier with the cosmetic results of silicone implants than with saline-filled ones, a study published Monday suggests.

close